Talcum Powder Lawsuit News
On Monday, a Los Angeles jury awarded damages of $417 million to Eva Echeverria in connection with her decades-long use of Johnson & Johnson Baby Powder for feminine hygiene purposes. Ms. Echeverria alleged her use of the talcum product caused her ovarian cancer.
California’s first trial alleging that Johnson & Johnson’s talcum powder products (Baby Powder and Shower-to-Shower Powder) have caused ovarian cancer in women who use the products for feminine hygiene will begin today in the Los Angeles Superior Court.
On Thursday, a Missouri state court jury ordered Johnson & Johnson to pay a Virginia woman more than $110 million based on her claim that she developed ovarian cancer after decades of using the company’s talcum powder products for feminine hygiene. The verdict is the largest yet in five trials raising similar claims.
Johnson & Johnson will face a fifth trial beginning April 10th alleging that its popular talcum powder products, baby powder and Shower-to-Shower, have caused ovarian or uterine cancer in women who used them for feminine hygiene. The first three trials resulted in jury verdicts for the women who brought them in the collective amount of $197 million. The fourth trial concluded with a jury verdict in favor of Johnson & Johnson and Imerys Talc America.
About 300 lawsuits against Johnson & Johnson in connection with its popular talcum powder products (J&J Baby Powder and Shower-to-Shower Powder) were consolidated earlier in Los Angeles Superior Court. The first trial on these cases presently is scheduled to begin on July 3rd.
On Friday, the fourth jury to hear a talcum powder cancer case returned a verdict in favor of Johnson & Johnson and Imerys Talc America. The jury split 11–1 on the decision against Nora Daniels of Columbia, Tennessee, who claimed that her ovarian and uterine cancer was caused by 36 years of using Johnson & Johnson baby powder for feminine hygiene. Ms. Daniels’ cancer was diagnosed in 2013.
A third St. Louis jury has awarded a California woman $70.1 million in connection with her use of Johnson & Johnson’s baby powder to keep her genital area dry. Deborah Giannecchini, age 63 of Modesto, reportedly used the product for 45 years. She now suffers from ovarian cancer, and has an 80 percent chance of dying within two years.
David Steinberg is a consultant and expert with more than 40 years experience in the cosmetic and over-the-counter industries. Among other services, Mr. Steinberg provides advice to cosmetic manufacturers on compliance with government regulations. Steinberg testified last week in the fourth trial against Johnson & Johnson brought by ovarian cancer victims who claim that their cancer was caused by the Company’s talcum powder products, Baby Powder and Shower-to-Shower Powder.
The United States Judicial Panel on Multidistrict Litigation ordered yesterday that eleven pending federal court cases against Johnson & Johnson involving claims that its talcum-based products (Baby Powder and Shower-to-Shower Body Powder) be consolidated in a single federal court. The Panel determined that the U.S. District Court of New Jersey was the most appropriate Court to preside over the pretrial proceedings in the Johnson & Johnson lawsuits.
A United Kingdom and Australia-based mining company, Rio Tinto Minerals, and its subsidiary, Luzenac America, have been sued along with Johnson & Johnson by four women and the husband of a fifth woman who died. All five women were diagnosed with ovarian cancer between 2011 and 2015. The women all used Johnson & Johnson Baby Powder or Shower-to-Shower Powder as feminine hygiene products.